Verbiance Lifesciences

Verbiance Lifesciences is a pharmaceutical company based in Hyderabad, India, specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms. The company serves a global clientele, providing high-quality chemical components for a variety of therapeutic areas, including cardiology, diabetology, and oncology. Verbiance Lifesciences offers comprehensive CDMO services, encompassing process research, development, and commercial-scale production. Their product portfolio features key molecules such as Apixaban, Sitagliptin, and Empagliflozin, which are essential for treating chronic conditions like cardiovascular disease and diabetes. The firm operates state-of-the-art facilities that adhere to international regulatory standards, ensuring the reliability and safety of its pharmaceutical products. By focusing on innovation and cost-effective manufacturing, Verbiance Lifesciences supports the global generic drug industry in delivering affordable healthcare solutions.